Artificial Axon Labs Analysis
What is Artificial Axon Labs?
Biomimetic platform for neurodegenerative drug discovery
Location
Topsfield, United States
Employees
1-10
Founded
2022
Product Features & Capabilities
- 3D-printed axon mimics
- Myelination quantification assays
- Drug screening platform for neurodegenerative diseases
Use Cases
Screen for remyelinating drugs in Multiple Sclerosis; Model myelin disorders in genetic variants of MS; Validate drug efficacy using human cell assays; Study human myelination processes; Investigate leukodystrophies using patient-derived cells
Other Considerations
Validated at MIT with industry collaborations; Won NIH SBIR Phase I award; Recognized in Sanofi IdeaTech 2023-24 award; Published research in collaboration with Sanofi
See something that needs updating? Suggest edits to this profile.